Comparison of Clinical Subtypes of Breast Cancer within the Claudin-Low Molecular Cluster Reveals Distinct Phenotypes.

Cancers (Basel) · 2023 · PMC10216296 · PMID 37345027

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In contrast mutations in TP53 are more prevalent in the claudin-low group, although the difference did not reach statistical significance and their prevalence (15.8%) is lower than in both basal and claudin-low ER-negative/HER2-negative cancers (86.9% and 29.8%, respectively, Table 4 and Table 8 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.